New Ray Medicine International Holding Limited

HKG-6108
Hong Kong Stock Exchange
Healthcare Pharmaceutical Retailers
Global Rank
#41311
Country Rank
#6483
Market Cap
9.26 M
Price
0.0561
Change (%)
6.02%
Volume
134,240

HKG-6108's Next Dividend

Next Estimated Amount
HK$0.00046
Next Estimated Pay Date
06/27/2014
Last Amount
HK$0.00046
Last Pay Date
06/27/2014
Dividend Shot Clock Ex-Date: 06/03/2014
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

New Ray Medicine International Holding Limited Dividend Chart

*Amounts are shown in the stock exchange currency (HKD) for convenience

New Ray Medicine International Holding Limited(HKG-6108) Dividend History

New Ray Medicine International Holding Limited (HKG-6108) currently pays an annual dividend of $0.00 per share, offering a dividend yield of 3.62%. The next dividend payout date has not been announced.
Ex-Dividend Date Amount Adj. Amount Dividend Yield Pay Date Change (%)
2014 HK$0.025 HK$0.00046
06/03/2014 HK$0.025 HK$0.00046 3.62% 06/27/2014
*Amounts are shown in the stock exchange currency (HKD) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.